DR. SETANA ABUBAKR IDRISS MD
Prescription History 1427518521
Internal Medicine - Endocrinology, Diabetes & Metabolism in Springfield, MA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. SETANA ABUBAKR IDRISS MD, an active Endocrinology, Diabetes & Metabolism specialist practicing in Springfield, MA. Our medical registry currently tracks 26 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 704 documented patient claims. Among these therapy options, the most frequently utilized medication is Levothyroxine Sodium, which accounts for 136 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other MA PrescribersVs. MA Avg |
|---|---|---|---|
| Levothyroxine Sodium | 136 | $15.15▼ below MA avg | ≈ Typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2023, this provider wrote 136 Medicare prescriptions for Levothyroxine Sodium, about 1.2 times the volume of the typical Massachusetts prescriber of this medication (117). Medicare paid an average of $15.15 per fill, versus $18.51 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 263.5 30-Day Fills standardized to 30-day supplies 7,873 Days of Medication total across all patients in 2023 | |||
| Methimazole | 60 | $12.51▼ below MA avg | ▲ More than typical |
About Methimazole: Methimazole is used to treat overactive thyroid (hyperthyroidism). Show more ▾ It works by stopping the thyroid gland from making too much thyroid hormone. A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme. In 2023, this provider wrote 60 Medicare prescriptions for Methimazole, about 1.8 times the volume of the typical Massachusetts prescriber of this medication (34). Medicare paid an average of $12.51 per fill, versus $13.55 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 92.1 30-Day Fills standardized to 30-day supplies 2,705 Days of Medication total across all patients in 2023 | |||
| Novolog FlexpenInsulin Aspart | 48 | $776.42▼ below MA avg | ≈ Typical |
About Novolog Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2023, this provider wrote 48 Medicare prescriptions for Novolog Flexpen, about 1.2 times the volume of the typical Massachusetts prescriber of this medication (39). Medicare paid an average of $776.42 per fill, versus $929.70 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 61.9 30-Day Fills standardized to 30-day supplies 1,853 Days of Medication total across all patients in 2023 | |||
| TrulicityDulaglutide | 47 | $937.51▼ below MA avg | ≈ Typical |
About Trulicity: Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment. In 2023, this provider wrote 47 Medicare prescriptions for Trulicity, about 82% of the volume of the typical Massachusetts prescriber of this medication (57). Medicare paid an average of $937.51 per fill, versus $1,274.01 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 47 30-Day Fills standardized to 30-day supplies 1,316 Days of Medication total across all patients in 2023 | |||
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 45 | $610.48 | ≈ Typical |
About Lantus Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 45 Medicare prescriptions for Lantus Solostar, about 1.3 times the volume of the typical Massachusetts prescriber of this medication (36). Medicare paid an average of $610.48 per fill, versus $606.42 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 74 30-Day Fills standardized to 30-day supplies 2,176 Days of Medication total across all patients in 2023 | |||
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 32 | $72.29▼ below MA avg | ▲ More than typical |
In 2023, this provider wrote 32 Medicare prescriptions for Ultra-Fine Mini Pen Needle, about 1.3 times the volume of the typical Massachusetts prescriber of this medication (24). Medicare paid an average of $72.29 per fill, versus $88.61 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 63.8 30-Day Fills standardized to 30-day supplies 1,878 Days of Medication total across all patients in 2023 | |||
| Hydrocortisone | 32 | $61.12 | ▲ More than typical |
About Hydrocortisone: Hydrocortisone is a man-made version of a natural substance (cortisol) made by the adrenal gland. Show more ▾ This drug is used to treat low cortisol levels caused by diseases of the adrenal gland (such as Addison's disease, adrenocortical insufficiency). Hydrocortisone belongs to a class of drugs known as corticosteroids. Corticosteroids are needed in many ways for the body to function well. They are important for salt and water balance and keeping blood pressure normal. The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. In 2023, this provider wrote 32 Medicare prescriptions for Hydrocortisone, about 1.3 times the volume of the typical Massachusetts prescriber of this medication (25). Medicare paid an average of $61.12 per fill, versus $20.55 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 51.8 30-Day Fills standardized to 30-day supplies 1,474 Days of Medication total across all patients in 2023 | |||
| BaqsimiGlucagon | 29 | $457.32▼ below MA avg | ▲ More than typical |
About Baqsimi: This medication is the same as your body's own glucagon, a natural substance that raises blood sugar by causing the body to release sugar stored in the liver. Show more ▾ It is used to treat very low blood sugar (hypoglycemia) that may cause you to need help from others. Make sure a family member or caregiver knows where you keep this medication and how to use it before you need their help. Peptides derived from proglucagon which is also the precursor of pancreatic GLUCAGON. Despite expression of proglucagon in multiple tissues, the major production site of glucagon-like peptides (GLPs) is the INTESTINAL L CELLS. GLPs include glucagon-like peptide 1, glucagon-like peptide 2, and the various truncated forms. In 2023, this provider wrote 29 Medicare prescriptions for Baqsimi, about 1.7 times the volume of the typical Massachusetts prescriber of this medication (17). Medicare paid an average of $457.32 per fill, versus $562.63 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 29 30-Day Fills standardized to 30-day supplies 465 Days of Medication total across all patients in 2023 | |||
| Alendronate Sodium | 23 | $10.26▼ below MA avg | ▼ Less than typical |
About Alendronate Sodium: Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. In 2023, this provider wrote 23 Medicare prescriptions for Alendronate Sodium, about half the volume of the typical Massachusetts prescriber of this medication (40). Medicare paid an average of $10.26 per fill, versus $12.60 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 62.7 30-Day Fills standardized to 30-day supplies 1,880 Days of Medication total across all patients in 2023 | |||
| JardianceEmpagliflozin | 23 | $644.19▼ below MA avg | ▼ Less than typical |
About Jardiance: Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Empagliflozin works by increasing the removal of sodium by your kidneys. In 2023, this provider wrote 23 Medicare prescriptions for Jardiance, about half the volume of the typical Massachusetts prescriber of this medication (41). Medicare paid an average of $644.19 per fill, versus $987.12 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 25 30-Day Fills standardized to 30-day supplies 706 Days of Medication total across all patients in 2023 | |||
| OzempicSemaglutide | 22 | $1,038.77▼ below MA avg | ▼ Less than typical |
About Ozempic: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment. In 2023, this provider wrote 22 Medicare prescriptions for Ozempic, about half the volume of the typical Massachusetts prescriber of this medication (43). Medicare paid an average of $1,038.77 per fill, versus $1,360.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 25.5 30-Day Fills standardized to 30-day supplies 741 Days of Medication total across all patients in 2023 | |||
| Humulin R U-500 KwikpenInsulin Regular, Human | 21 | $1,316.63▼ below MA avg | ▼ Less than typical |
About Humulin R U-500 Kwikpen: Inhaled insulin powder is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a short-acting insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This product is absorbed into the blood through your lungs. It starts working faster and lasts for a shorter time than regular insulin injected under the skin. It is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin). In 2023, this provider wrote 21 Medicare prescriptions for Humulin R U-500 Kwikpen, about 70% of the volume of the typical Massachusetts prescriber of this medication (30). Medicare paid an average of $1,316.63 per fill, versus $1,685.96 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 21.1 30-Day Fills standardized to 30-day supplies 567 Days of Medication total across all patients in 2023 | |||
| Metformin Hcl | 19 | $13.11 | ▼ Less than typical |
About Metformin Hcl: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2023, this provider wrote 19 Medicare prescriptions for Metformin Hcl, about a quarter of the volume of the typical Massachusetts prescriber of this medication (75). Medicare paid an average of $13.11 per fill, versus $10.76 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19 30-Day Fills standardized to 30-day supplies 546 Days of Medication total across all patients in 2023 | |||
| Tresiba Flextouch U-200Insulin Degludec | 17 | $814.53▼ below MA avg | ▼ Less than typical |
About Tresiba Flextouch U-200: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2023, this provider wrote 17 Medicare prescriptions for Tresiba Flextouch U-200, about half the volume of the typical Massachusetts prescriber of this medication (32). Medicare paid an average of $814.53 per fill, versus $1,285.07 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 21.1 30-Day Fills standardized to 30-day supplies 591 Days of Medication total across all patients in 2023 | |||
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 16 | $458.74 | ▼ Less than typical |
About Basaglar Kwikpen U-100: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 16 Medicare prescriptions for Basaglar Kwikpen U-100, about half the volume of the typical Massachusetts prescriber of this medication (30). Medicare paid an average of $458.74 per fill, versus $453.99 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 40.5 30-Day Fills standardized to 30-day supplies 1,215 Days of Medication total across all patients in 2023 | |||
| Glipizide | 15 | $15.88 | ▼ Less than typical |
About Glipizide: Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. An oral hypoglycemic agent which is rapidly absorbed and completely metabolized. In 2023, this provider wrote 15 Medicare prescriptions for Glipizide, about half the volume of the typical Massachusetts prescriber of this medication (34). Medicare paid an average of $15.88 per fill, versus $10.55 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23 30-Day Fills standardized to 30-day supplies 670 Days of Medication total across all patients in 2023 | |||
| Evenity (2 Syringes)Romosozumab-Aqqg | 13 | $2,351.59 | ▼ Less than typical |
About Evenity (2 Syringes): Romosozumab-aqqg is used to treat bone loss (osteoporosis) for women after menopause who are at high risk of having broken bones (fractures). Show more ▾ It works by increasing bone density and strength. This effect helps to decrease the risk of having a fracture. In 2023, this provider wrote 13 Medicare prescriptions for Evenity (2 Syringes), about 72% of the volume of the typical Massachusetts prescriber of this medication (18). Medicare paid an average of $2,351.59 per fill, versus $2,281.89 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 364 Days of Medication total across all patients in 2023 | |||
| Prednisone | 13 | $9.68 | ▼ Less than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 13 Medicare prescriptions for Prednisone, about a third of the volume of the typical Massachusetts prescriber of this medication (44). Medicare paid an average of $9.68 per fill, versus $6.86 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2023 | |||
| Somatuline DepotLanreotide Acetate | 13 | $6,514.16▼ below MA avg | ≈ Typical |
About Somatuline Depot: This medication is a long-acting form of lanreotide. Show more ▾ Lanreotide is used to treat a condition called acromegaly that occurs when the body makes too much of a certain natural substance called growth hormone. It is used when surgery or radiation treatment have not been fully successful or cannot be used. Treating acromegaly helps reduce the risk of serious problems such as diabetes and heart disease. Lanreotide works by decreasing the amount of growth hormone to normal levels. This drug is not a cure for acromegaly. It is used for the long-term treatment of this condition. This medication is also used to treat certain cancer or tumors of the stomach, intestines, or pancreas. It may help to slow down the growth of these tumors. Lanreotide is also used to treat carcinoid syndrome. It may help reduce the need to use another medication to treat diarrhea or flushing caused by carcinoid syndrome. In 2023, this provider wrote 13 Medicare prescriptions for Somatuline Depot, about the same volume as the typical Massachusetts prescriber of this medication (14). Medicare paid an average of $6,514.16 per fill, versus $7,655.08 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 13 30-Day Fills standardized to 30-day supplies 364 Days of Medication total across all patients in 2023 | |||
| Cabergoline | 13 | $28.44▼ below MA avg | ▼ Less than typical |
About Cabergoline: This medication is used to treat high levels of prolactin hormone in your body. Show more ▾ High levels of prolactin in women can cause symptoms such as unwanted breast milk and missed periods and can cause difficulty becoming pregnant. High levels of prolactin in men can cause symptoms such as enlarged breasts and decreased sexual ability/desire. Cabergoline is an ergot medication and works by blocking the release of prolactin from the pituitary gland. An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion. It is used in the management of HYPERPROLACTINEMIA, and to suppress lactation following childbirth for medical reasons. Cabergoline is also used in the management of PARKINSON DISEASE. In 2023, this provider wrote 13 Medicare prescriptions for Cabergoline, about half the volume of the typical Massachusetts prescriber of this medication (23). Medicare paid an average of $28.44 per fill, versus $125.54 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 13 30-Day Fills standardized to 30-day supplies 370 Days of Medication total across all patients in 2023 | |||
| Ultracare Insulin SyringeSyringe-Needle,insulin,0.5 Ml | 12 | $14.76▼ below MA avg | ≈ Typical |
In 2023, this provider wrote 12 Medicare prescriptions for Ultracare Insulin Syringe, about the same volume as the typical Massachusetts prescriber of this medication (13). Medicare paid an average of $14.76 per fill, versus $25.89 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 12 30-Day Fills standardized to 30-day supplies 300 Days of Medication total across all patients in 2023 | |||
| Humalog Kwikpen U-100Insulin Lispro | 11 | $1,010.09 | ▼ Less than typical |
About Humalog Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2023, this provider wrote 11 Medicare prescriptions for Humalog Kwikpen U-100, about a third of the volume of the typical Massachusetts prescriber of this medication (32). Medicare paid an average of $1,010.09 per fill, versus $970.50 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24.8 30-Day Fills standardized to 30-day supplies 728 Days of Medication total across all patients in 2023 | |||
| NovologInsulin Aspart | 11 | $1,168.78 | ▼ Less than typical |
About Novolog: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2023, this provider wrote 11 Medicare prescriptions for Novolog, about a third of the volume of the typical Massachusetts prescriber of this medication (29). Medicare paid an average of $1,168.78 per fill, versus $901.78 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22.9 30-Day Fills standardized to 30-day supplies 685 Days of Medication total across all patients in 2023 | |||
| FarxigaDapagliflozin Propanediol | 11 | $544.90▼ below MA avg | ▼ Less than typical |
About Farxiga: Dapagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used in people with type 2 diabetes and heart disease to lower the risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sugar by your kidneys. Dapagliflozin is also used to treat kidney disease and heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sodium by your kidneys. In 2023, this provider wrote 11 Medicare prescriptions for Farxiga, about a third of the volume of the typical Massachusetts prescriber of this medication (33). Medicare paid an average of $544.90 per fill, versus $883.02 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
| Prednisolone Sodium Phosphate | 11 | $298.01 | ▼ Less than typical |
About Prednisolone Sodium Phosphate: Prednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. Show more ▾ It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain and allergic-type reactions. This medication is a corticosteroid hormone. Prednisolone may also be used with other medications in hormone disorders. In 2023, this provider wrote 11 Medicare prescriptions for Prednisolone Sodium Phosphate, about a third of the volume of the typical Massachusetts prescriber of this medication (27). Medicare paid an average of $298.01 per fill, versus $57.81 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
| Testosterone | 11 | $137.78▼ below MA avg | ▼ Less than typical |
About Testosterone: This medicated patch contains testosterone. Show more ▾ It is used for hormone replacement in men who are not able to produce enough testosterone (for example, due to hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels. Testosterone helps the body to develop and maintain the male sexual characteristics (masculinity), such as a deep voice and body hair. It also helps to maintain muscle and prevent bone loss, and is necessary for natural sexual ability/desire. This drug should not be used by women. A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. In 2023, this provider wrote 11 Medicare prescriptions for Testosterone, about a third of the volume of the typical Massachusetts prescriber of this medication (27). Medicare paid an average of $137.78 per fill, versus $238.94 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 11 30-Day Fills standardized to 30-day supplies 255 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. SETANA ABUBAKR IDRISS MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Endocrinology, Diabetes & Metabolism prescribing approach at this Springfield, MA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among MA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
